View
12
Download
0
Category
Preview:
Citation preview
NobuyukiMatobaCV
1
NobuyukiMatoba,Ph.D.
ClinicalandTranslationalResearchBuilding,Room615505S.HancockStreetLouisville,KY40202
OfficePhone:(502)8528412Fax:(502)8525468
E-mail:n.matoba@louisville.eduEDUCATION
1992–1996 B.Sc.inFoodBioscienceandTechnology,FacultyofAgriculture,KyotoUniversity,
Japan1996–1998 M.Sc.inAppliedLifeScience,GraduateSchoolofAgriculture,KyotoUniversity,
Japan(Advisor:MasaakiYoshikawa,Ph.D.)1998–2001 Ph.D.(AppliedLifeScience),GraduateSchoolofAgriculture,KyotoUniversity,
Japan(Advisor:MasaakiYoshikawa,Ph.D.)ACADEMICAPPOINTMENTS1/2006–9/2008 ResearchAssistantProfessor
CenterforInfectiousDiseases&Vaccinology,BiodesignInstitute,ArizonaStateUniversity,Tempe,AZ
10/2008–12/2013 AssistantProfessor(tenuretrack)DepartmentofPharmacologyandToxicology,UniversityofLouisvilleSchoolofMedicine,Louisville,KY
1/2014–present AssociateProfessor(withtenure)DepartmentofPharmacologyandToxicology,UniversityofLouisvilleSchoolofMedicine,Louisville,KY
10/2008–present ScientistJamesGrahamBrownCancerCenter,UniversityofLouisvilleSchoolofMedicine,Louisville,KY
OTHERPOSITIONSANDEMPLOYMENT2001 PostdoctoralAssociate
ResearchInstituteforFoodScience,KyotoUniversity(Advisor:MasaakiYoshikawa,Ph.D.)
2001–2002 VisitingScientist DepartmentofPlantBiology,ArizonaStateUniversity(Sponsor:TsafrirMor,Ph.D.)
2002–2004 PostdoctoralResearchAssociateDepartmentofPlantBiology,ArizonaStateUniversity(Advisor:TsafrirMor,Ph.D.)
2004–2005 FacultyResearchAssociate
NobuyukiMatobaCV
2
CenterforInfectiousDiseases&Vaccinology,BiodesignInstituteandSchoolofLifeSciences,ArizonaStateUniversity,Tempe,AZ(Advisors:CharlesArntzen,Ph.D.andTsafrirMor,Ph.D.)
CERTIFICATIONANDLICENSURENotapplicable
PROFESSIONALMEMBERSHIPSANDACTIVITIES2008–present MemberoftheSocietyforMucosalImmunology2010–present MemberofKentuckyAcademyofScience2013–present MemberofAmericanSocietyforMicrobiology2014–present MemberoftheProteinSocietyHONORSANDAWARDS
1996–1999 GraduateScholarship,JapanScholarshipFoundation2000–2002 ResearchFellowshipforYoungScientists,JapanSocietyforthePromotionof
Science2004–2006 PostdoctoralFellowshipforResearchAbroad,JapanSocietyforthePromotionof
Science03/2005 TravelAward,KeystoneSymposiumonHIVVaccines:CurrentChallengesand
FutureProspects06/2005 YoungInvestigatorAward,AnnualmeetingoftheSocietyforMucosal
Immunology03/2008 ScholarshipAward,KeystoneSymposiaFellowsandNewInvestigatorsWorkshop
onGrantsmanshipandCareerResearchOpportunitiesinHIV/AIDSResearch11/2009 RogerH.HerzigJuniorFacultyResearchPrize(3rdplace),JamesGrahamBrown
CancerCenter8thAnnualRetreat05/2010 ScholarshipAward,2010InternationalMicrobicideConference05/2014 2014ScientistoftheYear,JamesGrahamBrownCancerCenter,Universityof
LouisvilleCOMMITTEEASSIGNMENTSANDADMINISTRATIVESERVICESServicetotheDepartment
2009–2014 Member,EventCommittee,DepartmentofPharmacology&Toxicology,UniversityofLouisvilleSchoolofMedicine
2009–2014 Organizer,JournalClubatOwensboroCancerResearchProgram2011–2015 OwensboroCancerResearchProgramFacultySearchCommittee
NobuyukiMatobaCV
3
2014–present Chair,SIBUP(salaryincreasesbaseduponperformance)/GrievanceCommittee,DepartmentofPharmacology&Toxicology,UniversityofLouisvilleSchoolofMedicine
ServicetotheUniversity
2009–2013,2017 Judge,Research!Louisville2014–present Member,InstitutionalBiosafetyCommittee,UniversityofLouisvilleServicetothecommunity,State,Nationorinternationalorganizations
2010 Judge,BiochemistrysectionofLouisvilleRegionalScienceFairs2009–present AssociateFacultyMember,Facultyof1000Biology2011 Grantreviewer,NationalResearchFoundation,theRepublicofSouthAfrica2013 Grantreviewer,theNazarbayevUniversityResearchCouncilinAstana,
Kazakhstan2015 Grantreviewer,NIH/NIAIDSpecialEmphasisReviewPanel(ZAI1-JBS-A-M1),
SustainedReleaseforAntiretroviralTreatmentorPrevention(SRATP)ofHIVInfection(UM1)
2016 Grantreviewer,NIH/NIAIDSpecialEmphasisReviewPanel(ZRG1AARR-M54),PreventionInnovationProgramIII(R01)
2017 Grantreviewer,NaturalSciencesAndEngineeringResearchCouncil(NSERC)CollaborativeResearchandDevelopment(CRD)GrantProgram,Canada
EDUCATIONALACTIVITIESCoursesorganizedorinstructed
2006–2008 Guestinstructor,MCB500Strategiesforproductionofrecombinantprotein-pharmaceuticals,ArizonaStateUniversitySchoolofLifeSciences
2010–2015 Organizer,JournalClubsessionforsummerresearchinternstudentsatOwensboroCancerResearchProgram,OwensboroMedicalHealthSystemandUniversityofLouisvilleSchoolofMedicine
2010–2016 Guestinstructor,PHTX675ResearchMethodsinPharmacologyandToxicology,UniversityofLouisvilleSchoolofMedicine(GeneticScreeningandPhageDisplayforNewAntibodyTherapeutics)
2017 Guestinstructor,PHTX642GraduatePharmacologyIISpring2016(AntiviralandAntiretroviralAgents)
2017 GuestinstructorofPHTX641GraduatePharmacologyI,Fall2017(AntiviralDrugs)
2017 GuestinstructorofBMSC807-05_4178PharmacologyandDentalTherapeutics,Fall2017(DrugsActingontheGastrointestinalTract)
Lecturesinformalcoursesandinvitedseminars
NobuyukiMatobaCV
4
06/2004 Guestlectureon“Heat-stable,OralVaccinesFromTransgenicPlants”AdvancedBiotechnologyCourse(Graduatelevel,Bioengineering),OsakaUniversity
3/2005 Guestlectureon“ConstructingamucosalsubunitvaccinetopreventHIV-1transmissionandinfection”MCB701MolecularCellularBiologyColloquium,ArizonaStateUniversity
12/2007 Guestlectureon“PlantBiotechnologyforHumanHealth”SpeciallectureseriesintheFoodScienceandBiotechnologymajor,KyotoUniversityGraduateSchoolofAgriculture
06/2009 Guestlectureon“BioProductionofRecombinantProteinPharmaceuticalsinPlants”FacultyofPharmacyUndergraduateCourse,IwakiMeiseiUniversity
10/2009 Guestlectureon“ProductionofRecombinantProteinPharmaceuticalsinPlants”BiotechnologyCourse,DepartmentofBiology,WesternKentuckyUniversity
10/2009 Guestlectureon“PlantBiotechnologyforHumanHealth:ProductionofRecombinantProteinPharmaceuticalsinPlants”KentuckyWesleyanCollegeGeneticsCourse(undergraduatelevel)
06/2013 Guestlectureon“DevelopmentofProteinPharmaceuticalsBasedonMolecularFarming”FacultyofAgriculture,TheUniversityofTokyo
06/2013 Guestlectureon“MolecularFarmingofBiopharmaceuticals”FacultyofPharmacyUndergraduateCourse,IwakiMeiseiUniversity
06/2013 Guestlectureon“MolecularFarmingofBiopharmaceuticals”FacultyofAgriculture,KyotoUniversity
07/2013 Guestlectureon“MolecularFarmingofRecombinantProteinPharmaceuticals”FacultyofEngineering,OsakaUniversity
07/2015 Invitedseminaron“Therapeutic effects of a cholera toxin vaccine antigen produced in Nicotiana benthamiana plants”Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan
07/2015 Guestlectureon“Molecular farming of protein pharmaceuticals” Tokyo University of Agriculture, Tokyo, Japan
07/2015 Invitedseminaron“Molecular Farming of Protein Pharmaceuticals” Kanazawa University Medical School, Kanazawa, Japan
11/2015 Invitedseminaron“Engineering of a lectibody targeting viral- and tumor-associated high-mannose glycans” Department of Chemical Engineering and Materials Science, University of California Davis
2/2016 Invitedseminar“Oraladministrationofacholeravaccineantigeninducesmucosalhealinginthecolon”PriceInstituteforSurgicalResearch,DepartmentofSurgery,UniversityofLouisvilleSchoolofMedicine
3/2016 Invitedseminar“Anoligomannose-specificlectin-FcfusionproteinagainstHIVinfection”DepartmentofMicrobiologyandImmunology,UniversityofLouisvilleSchoolofMedicine
4/2016 “Plantviralvector-basedtransientexpressionforrapidscreeningandcharacterizationofnovelproteinpharmaceuticals”ThePhyto-EngineeringResearchCenterworkshop,UniversityofCaliforniaDavis
3/2017 Invitedseminar,“Plant-madebiopharmaceuticals”DepartmentofBioengineeringSpring2017seminarseries,UniversityofLouisville
NobuyukiMatobaCV
5
11/2017 Invitedseminar“ThecolonepithelialhealingactivityofEpicertin,acholeratoxinBsubunitvariant”PriceInstituteforSurgicalResearch,DepartmentofSurgery,UniversityofLouisvilleSchoolofMedicine,November9,2017.
Ph.D.andMasterthesiscommittee
2006–2008 CommitteeMemberforMs.NamrataShah,M.S.studentofMolecularCellularBiology,SchoolofLifeSciences,ArizonaStateUniversity
2006–2012 CommitteeMemberforMs.SarahKessans,Ph.D.studentofMolecularCellularBiology,SchoolofLifeSciences,ArizonaStateUniversity
2009–2014 CommitteeMemberforMr.ChristopherBarton,Ph.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
01/2012–12/2015 CommitteeChairforMr.KeeganBaldauf,Ph.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
12/2012–05/2016 CommitteeMemberforMs.AmandaLasnik,Ph.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
01/2016–present CommitteeChairforMr.JoshuaRoyal,Ph.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
07/2016–present CommitteeMemberforMr.KevinTyo,Ph.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
08/2016–present CommitteeChairforMr.MatthewDent,Ph.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
Advisorforpostdoctoralfellows,Ph.D./Masterstudents
10/2010–12/2010 Co-advisor(withDr.Palmer)forMs.HuihuiWuduringherlabrotationoffirst-yearPh.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
08/2010–02/2012 Co-advisor(withDr.Palmer)forJosephCalvinKoukam,Ph.D.,PostdoctoralScholar
09/2010–03/2014 MajorAdvisorforKrystalTeasleyHamorsky,Ph.D.,PostdoctoralResearchAssociate(PromotedtoInstructorofMedicineatUniversityofLouisville)
01/2012–09/2015 MajorAdvisorforTiffanyGrooms-Williams,Ph.D.,PostdoctoralResearchAssociate
08/2012–02/2013 MajorAdvisorforMs.AprilAlloway,Ph.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
01/2012–12/2015 MajorAdvisorforMr.KeeganBaldauf,Ph.D.studentofPharmacologyandToxicologyatUniversityofLouisvilleSchoolofMedicine
02/2015–10/2016 MajorAdvisorforSugataRoyChowdhury,Ph.D.,PostdoctoralResearchAssociate08/2016–present MajorAdvisorforMr.MatthewDent,M.S.,PhDstudentofPharmacologyand
Toxicology,UniversityofLouisvilleSchoolofMedicine09/2016–present MajorAdvisorforYoungjunOh,Ph.D.,VisitingScientist/PostdoctoralAssociateMentoringofundergraduateandhigh-schoolstudents
03/2005–05/2007 Mr.TaganGriffin,ArizonaStateUniversity
NobuyukiMatobaCV
6
04/2006–08/2007 Mr.HowardCheng,CoronadelSolHighSchool04/2006–10/2007 Mr.JonathanHu,CoronadelSolHighSchool05/2007–08/2008 Ms.MichellePickel,ArizonaStateUniversity11/2007–05/2008 Ms.JenniferHurt,ArizonaStateUniversity05/2008–08/2008 Ms.PriyaRaman,YaleUniversity05/2008–09/2008 Ms.HarmanDhatt,ArizonaStateUniversity02/2009–08/2009 Ms.HillaryConway,KentuckyWesleyanCollege06/2009–08/2009 Mr.DavidGrunewald,SaintLouisUniversity09/2009–12/2009 Ms.NancyPettiborne,OwensboroCommunity&TechnicalCollegeandWestern
KentuckyUniversity12/2009–07/2010 Ms.BrittneyMetts,KentuckyWesleyanCollege03/2010–08/2010 Mr.AndrewDonovan,KentuckyWesleyanCollege06/2010–08/2010 Mr.DavidGrunewald,SaintLouisUniversity07/2010–07/2011 Ms.AshleyHumphrey,KentuckyWesleyanCollege05/2011–08/2011 Ms.NatoshaMulholland,WesternKentuckyUniversity05/2011–08/2011 Mr.SamuelAsante,LindseyWilsonCollege,KY02/2011–05/2012 Ms.LaurenBennett,KentuckyWesleyanCollege05/2012–08/2012 Ms.BaileyNelson,CentreCollege,KY05/2012–08/2013 Mr.DanielSpeer,KentuckyWesleyanCollege,KY06/2014–08/2014 Mr.LukeRoyal,LindseyWilsonCollege,KY06/2015–07/2015 Mr.JeremiahWayne,TheGattonAcademy,KY06/2015–07/2015 Mr.GrahamReynolds,TheGattonAcademy,KY09/2015–06/2016 Mr.NehalNinad,UniversityofSouthernIndiana,IN05/2017–present Mr.DavidMorris,UniversityofLouisville,KY06/2018–08/2018 Mr.ChanduKona,NorthOldhamHighSchool,KYCLINICALACTIVITIESNotapplicableGRANTSANDCONTRACTSActiveGrants/Contracts
1. FundingAgency: NIHGrantNumber: U19AI113182CoreC(Matoba)FundingAmount: $2,138,020(directcosts)and$362,683(F&A)Duration: 7/01/14–6/30/19ProjectTitle: Griffithsin-basedRectalMicrobicidesforPREventionofViralENTry(PREVENT)
PharmacokineticsandPharmacodynamicsCoreRole: PI,25%effort
2. FundingAgency: NIH
GrantNumber: 1R21CA216447-01A1(Matoba)
NobuyukiMatobaCV
7
FundingAmount: $239,250(directcosts)and$136,986(F&A)Duration: 2/08/18–1/31/20 ProjectTitle: Investigationofalectibodytargetingtumor-associatedoligomannoseglycansRole: PI,15%effort
3. FundingAgency: NIH
GrantNumber: U10HL127518-01(Bates/Miller/Krentsel;co-PIs)FundingAmount: $200,000(subprojectdirectcosts)Duration: 2/01/16–1/31/19 ProjectTitle: TheEXCITEProgram:ExpeditingCommercialization,Innovation,Translation
andEntrepreneurshipPilotProjectTitle: OralsoliddosageformulationofcholeratoxinBsubunit.Role: Subprojectco-PI(withHamorsky),5%effort
4. FundingAgency: NIHGrantNumber: U10HL127518-01(Bates/Miller/Krentsel;co-PIs)FundingAmount: $200,000(subprojectdirectcosts)Duration: 3/01/17–2/28/19 ProjectTitle: TheEXCITEProgram:ExpeditingCommercialization,Innovation,Translation
andEntrepreneurshipPilotProjectTitle: Avaren-FclectibodyforlivergraftprotectionagainsthepatitisCvirusinfectionRole: SubprojectPI(withHamorsky),5%effort
5. FundingAgency: NIH
GrantNumber: U10HL127518-01(Bates/Miller/Krentsel;co-PIs)FundingAmount: $100,000(subprojectdirectcosts)Duration: 9/01/17–8/31/18 ProjectTitle: TheEXCITEProgram:ExpeditingCommercialization,Innovation,Translation
andEntrepreneurshipPilotProjectTitle: CTBpfororalmucositistreatmentRole: SubprojectPI(withHamorsky),5%effort
6. FundingAgency: NIH
GrantNumber: T32ES011564(DavidHein)FundingAmount: $2,037,745(total)Duration: 7/01/16–6/30/21 ProjectTitle: UofLEnvironmentalHealthSciencesTrainingProgram.Role: Facultymentor(nosalarysupport)
7. FundingAgency: NIHGrantNumber: R25-CA134283(DavidW.Hein;LaCreisR.Kidd)FundingAmount: $1,593,000(total)Duration: 04/01/17–03/31/22 ProjectTitle: UniversityofLouisvilleCancerEducationProgram.
NobuyukiMatobaCV
8
Role: Facultymentor(nosalarysupport)CompletedGrants/Contracts
1. FundingAgency: JapanSocietyforthePromotionofScienceProgram: ResearchGrantforJSPSResearchFellow(Matoba)FundingAmount: 2,000,000JPY(directcosts)Duration: 1/1/2000–3/31/2002ProjectTitle: DevelopmentofFoodCropsPossessingAnti-HypertensiveActivityRole: PI,100%effort
2. FundingAgency: JapanSocietyforthePromotionofScience
Program: ResearchGrantforJSPSPostdoctoralFellow(Matoba)FundingAmount: 1,040,000JPY(directcosts)Duration: 4/1/2004–3/31/2006 ProjectTitle: ConstructionofPlant-BasedMucosalVaccinesAgainstHIVRole: PI,100%effortFundingAgency: NIH/NIAID
3. GrantNumber: R03AI073157(Matoba)FundingAmount: $100,000(directcosts)Duration: 3/15/2007–2/28/2010ProjectTitle: ExpressionofDeconstructedHIV-1Virus-LikeParticlesinBioengineeredPlantsRole: PI,50%effort(3/15/2007–12/31/2008);and10%effort(1/1/2009–
2/28/2010)
4. FundingAgency: UniversityofLouisvilleSchoolofMedicineGrantNumber: BasicGrantProgramE0581(Matoba)FundingAmount: $15,000(directcosts)Duration: 4/1/2009–3/31/2010ProjectTitle: ProductionandEvaluationofPlant-madeAnti-HIVProteinActinohivinRole: PI,20%effort(nosalarysupport)
5. FundingAgency: UniversityofLouisvilleGrantNumber: ClinicalandTranslationalSciencePilotGrantProgramAward-20002(Matoba)FundingAmount: $50,000(directcosts)Duration: 3/1/2010–2/28/2011ProjectTitle: Abroad-spectrumvaccineagainstenvelopedvirusesRole: PI,20%effort(nosalarysupport)
6. FundingAgency: UniversityofLouisvilleOfficeoftheVicePresidentforResearchGrantNumber: IRIGResearchInitiationGrant50721(Matoba) FundingAmount: $5,000 (directcosts)Duration: 06/01/11–11/30/12
NobuyukiMatobaCV
9
ProjectTitle: Prophylacticpotentialofplant-producedcholeratoxinBsubunitsinexperimentalcolitis.
Role: PI,10%effort(nosalarysupport)
7. FundingAgency: UniversityofLouisvilleOfficeoftheVicePresidentforResearchGrantNumber: IRIGCompetitiveEnhancementGrant50730(Matoba)FundingAmount: $15,000(directcosts)Duration: 10/01/11–12/31/12ProjectTitle: Developmentofarecombinantentry/fusion-bispecificinhibitortowarda
topicalHIV-1microbicide. Role: PI,10%effort(nosalarysupport)
8. FundingAgency: DoD/USMRAA/TATRCGrantNumber: W81XWH-09-2-0022(DonaldC.WilkersonatOMHS)FundingAmount: $1,680,000(totalcosts)Duration: 03/15/09–03/14/13ProjectTitle: DevelopmentofNovelVaccinesandTherapeuticsUsingPlant-BasedExpression
SystemsRole: Sub-projectPI,10%effort
9. FundingAgency: DoD/USMRAA/TATRCGrantNumber: W81XWH-10-2-0082-CLIN1(DonaldC.WilkersonatOMHS)FundingAmount: $1,751,000(total)Duration: 8/23/2010–9/22/2013ProjectTitle: Plant-BasedExpressionSystemsforNewVaccinesandTherapeuticsRole: Sub-projectPI,10%effort
10. FundingAgency: NIHGrantNumber: R21/R33AI088585(Matoba)FundingAmount: $1,175,000(directcosts)Duration: 6/10/2010–6/31/2016ProjectTitle: Plant-producedActinohivinasaCandidateHIVMicrobicideRole: PI,30%effort
11. FundingAgency: DoD/USMRAA/TATRC
GrantNumber: W81XWH-10-2-0082-CLIN2(Wilkerson)FundingAmount: $1,748,000(total)Duration: 9/30/2011–10/31/2016 ProjectTitle: Plant-BasedExpressionSystemsforNewVaccinesandTherapeuticsRole: SubprojectPI,5%effort
12. FundingAgency: NIHGrantNumber: T32ES011564(DavidW.Hein)FundingAmount: $2,037,745(total)
NobuyukiMatobaCV
10
Duration: 7/01/09–6/30/14 ProjectTitle: UofLEnvironmentalHealthSciencesTrainingProgram.Role: Facultymentor(nosalarysupport)
13. FundingAgency: NIHGrantNumber: R25-CA134283(DavidW.Hein)FundingAmount: $1,543,610(total)Duration: 09/14/11–08/30/16 ProjectTitle: UniversityofLouisvilleCancerEducationProgram.Role: Facultymentor(nosalarysupport)
14. FundingAgency: NIHGrantNumber: P30GM106396(Miller)FundingAmount: $150,000(pilotprojectdirectcosts)Duration: 7/01/15–6/30/17 ProjectTitle: MolecularTargetsPhaseIIICoBREPilotProjectTitle: Plant-madelectibodytargetingtumor-associatedhigh-mannose-glycan
antigensasanovelcancerimmunotherapeutic/diagnosticagent.Role: PilotprojectPI,5%effort
15. FundingAgency: HelmsleyCharitableTrustGrantNumber: 2014-PG-MED001(Miller)FundingAmount: $225,000(subprojectdirectcosts)Duration: 11/01/15–6/30/18ProjectTitle: Advancingthediscoveryanddevelopmentofplant-madepharmaceuticals SubProjectTitle: Plant-madeN-mannosylatedcholeratoxinBsubunitasanovelvaccinescaffold.Role: SubprojectPI,5%effort
PATENTSAwarded
1. US7438914B2(AwardDate:10/21/2008)Title:CompositionandMethodforEnhancingImmuneResponse
2. US7927833B2(AwardDate:4/19/2011)Title:CompositionandMethodforEnhancingImmuneResponse
1. US8802822B2(AwardDate:8/12/2014)Title:Polypeptideshavingantiviralactivityandmethodsforusethereof
2. US9133252B2(AwardDate:9/15/2015)Title:Polypeptideshavingantiviralactivityandmethodsforusethereof
Applications
1. ApplicationDate:March14,2012
NobuyukiMatobaCV
11
ApplicationNumber:PCT/US2012/029072Title:Polypeptideshavingimmunoactivatingactivityandmethodsofproducingthesame
2. ApplicationDate:February11,2014ApplicationNumber.PCT/US2014/015861Title:Methodsforproducingantibodies
3. ApplicationDate:July16,2014ApplicationNumber.PCT/US2014/046893Title:Compositionsformucosaldelivery,usefulfortreatingpapillomavirusinfections
4. ApplicationDate:Jun29,2016ApplicationNumber.PCT/US2016/040041Title:Compositionsandmethodsfortreatingcancerandpromotingwoundhealing
EDITORIALWORKJournalEditorialBoards,AdvisoryCouncils,PeerReviewerofManuscripts
09/2009–present AssociateFaculty,Facultyof1000BiologyAgricultureandBiotechnologysection11/2004–present Adhocmanuscriptreviewerfor: BiotechnologyJournal;CellularandMolecular
LifeScience;CurrentMedicinalChemistry;ExpertReviewofVaccine;FASEBJournal;HortScience;JournalofAntimicrobialChemotherapy;JournalofBioscienceandBioengineering;JournalofVisualizedExperiments;MolecularBiologyReport;MolecularBiotechnology;NatureBiotechnology;PlantBiotechnologyJournal;PLoSONE;PNAS;ProcessBiochemistry;Vaccine
6/2015–present EditorialBoardmember,ScientificReports7/2017–present AssociateEditor,FrontiersinPlantScienceABSTRACTSANDPRESENTATIONSOralPresentations:National/InternationalMeetings
1. MatobaN,BomselM,ArntzenCJandMorTS.“TowardsamucosalvaccineagainstHIV”inCongressonInVitroBiology,Portland,OR,May31–June4,2003
2. MatobaN,MorTSandArntzenCJ.“Heat-stableoralvaccinesfromtransgenicplants”inPharmaceuticalSciencesWorldCongress2004,Kyoto,Japan,May30–June3,2004.(Invitedtalk)
3. MatobaN,MagérusA,GeyerBC,AlfsenA,HansonCV,ArntzenCJ,BomselMandMorTS.“HumoralimmunityinducedbyCTB-MPR649-684forthepreventionofHIV-1mucosaltransmission/infection”inPlant-BasedVaccine&Antibodies,Prague,CzechRepublic,June8–10,2005.
4. BarnettB,ConwayH,HuskA,PickelM,ArntzenC,ZhangP,QuinnanG,MooneyJ,HansonC,TakahashiA,TannoK,TanakaH,andMatobaN.“Developmentofarobustandrapidplant
NobuyukiMatobaCV
12
expressionsystemforActinohivin,anovelanti-HIV-1proteintargetingtheenvelopehigh-mannosecluster”Plant-madePharmaceuticalsMeeting,Louisville/Owensboro,KY,June2009.
5. HamorskyK,SankaranS,DavisK,PalmerK,MatobaN.“HighlyefficientproductionofrecombinantcholeratoxinBsubunitformassvaccinationagainstcholera”TheGordonConferenceTropicalInfectiousDiseases,March13–18,Galveston,TX.
6. MatobaN,BaldaufK,HuskA,MorrisMK,HamorskyK,PalmerK,HansonC.“ANovel,Non-ARV-BasedTopicalHIV-1MicrobicideCandidateTargetingViralHigh-MannoseGlycans.”2ndAntiviralsCongress,Cambridge,MA,November2012.
7. MatobaN.“BioProductionofRecombinantProteinPharmaceuticalsinPlants”.InvitedKeynoteSpeakeratSymposiumonPlantBiotechIndustryNowandFutureinNiigata.Niigata,Japan,April2013.
8. Husk A*, Kasinger L, Hamorsky K, Matoba N. “Engineering, characterization, and anti-HIV activity of a bispecific HIV entry inhibitor” Plant-Based Vaccines, Antibodies & Biologics. June 8 – 10, 2015, Lausanne, Switzerland.
9. Royal J*, Baldauf K, Kouokam J, Matoba N. “Plant-made cholera toxin B subunit as a candidate oral immunotherapeutic agent against ulcerative colitis” Plant-Based Vaccines, Antibodies & Biologics. June 8 – 10, 2015, Lausanne, Switzerland.
10. Fuqua J*, Riedel S, Lasnik A, Walker J, Hamorsky K, Matoba N, Palmer K. “Mucosal delivery of a L2-based fusion vaccine provides cross-neutralizing protection against multiple HPV types” Plant-Based Vaccines, Antibodies & Biologics. June 8 – 10, 2015, Lausanne, Switzerland.
11. Hamorsky K*, Kouokam J, McMullen J, Nelson B, Bennett L, Husk A, Kajiura H, Fujiyama K, Matoba N. “N-Glycosylation of cholera toxin B subunit in Nicotiana benthamiana: Impacts on host stress response, production yield and vaccine potential” Plant-Based Vaccines, Antibodies & Biologics. June 8 – 10, 2015, Lausanne, Switzerland.
12. Matoba N*. “The PREVENT integrated preclinical development program to develop plant-produced Griffithsin as a topical microbicide” Plant-Based Vaccines, Antibodies & Biologics. June 8 – 10, 2015, Lausanne, Switzerland.
13. Matoba N*, Hamorsky K, Husk A, Kouokam C, Grooms T, Morris MK, Hanson C, Hume S, Vausselin T, Dubuisson J. “Plant virus vector-based engineering and production of AvFc, a novel lectin-Fc fusion protein with broad anti-HIV/HCV activity.” Plant-Based Vaccines, Antibodies & Biologics. June 8 – 10, 2015, Lausanne, Switzerland.
14. Matoba N*. “Plant viral vectors for efficient bioproduciton of protein pharmaceuticals in plants” The 27th International Conference on Arabidopsis Research, Gyeongju, South Korea, June 29 – July 3, 2016. Invited Talk, Session Chair (Plant Biotech).
15. Matoba N*. “Rapid Engineering and Production of Novel Biopharmaceuticals Using a Plant Viral Vector System” The 16th Annual PepTalk- Plant-Based Expression and Synthetic Biology, January 10 – 11, 2017, San Diego, CA. Invited Talk.
16. Royal J*, Baldauf K, Yaddanapudi K, Dryden GW, Matoba N. “Epicertin, a cholera toxin B subunit variant, enhances intestinal wound healing in a mouse acute colitis model and human ulcerative colitis colon explants via an unfolded protein response” Digestive Disease Week 2018, Washington, D.C., June 2 – 5, 2018. Mr. Royal received a Basic Science Travel Award.
NobuyukiMatobaCV
13
OralPresentations:Local/RegionalMeetings
1. YoshikawaM,MatobaN,NakagiriRandSasakiR.“OvokininisanagonistforangiotensinAT2receptors”MeetingofTheJapanesePeptideSociety,Tsukuba,Japan,October1996.
2. MatobaN,NakagiriR,SasakiRandYoshikawaM.“Designofpotentanti-hypertensivepeptidesbasedonovokininandcharacterizationoftheanti-hypertensiveactivity”AnnualmeetingofJapanSocietyforBioscience,Biotechnology,andAgrochemistry,Tokyo,Japan,April1997.
3. MatobaN,AlfsenA,BomselM,HansonCV,ArntzenCJandMorTS.“DevelopingVaccinesAimedatBlockingHIV-1Transmission”inAnnualmeetingofJapanSocietyforBioscience,Biotechnology,andAgrochemistry,Kyoto,Japan,April2006
4. MatobaN,MittmanM,GriffinTA,CherniIandMorTS.“ExpressionofamucosalsubunitHIV-1vaccinecandidateintransgenicN.benthamiana”inAnnualmeetingofJapanSocietyforBioscience,Biotechnology,andAgrochemistry,Tokyo,Japan,March2007.
5. HamorskyK,BaldaufK,MatobaN.“Large-scaleproductionofrecombinantproteinsinplantsenablingmucosaldeliveryofbiotherapeuticsbasedonnanotechnology.KYNanotechSymposium,Louisville,KY,August2013.
PosterPresentations:National/InternationalMeetings
1. MatobaN,BomselM,ArntzenCJandMorTS.“ImmunostimulatoryeffectofaHIVenvelope-derivedpeptide”in11thInternationalCongressofMucosalImmunology,Orlando,FL,June16–20,2002.
2. MatobaN,MagérusA,GeyerBC,AlfsenA,HansonCV,ArntzenCJ,BomselMandMorTS.“HumoralimmunityinducedbyCTB-P1forthepreventionofHIV-1mucosaltransmission/infection”inkeystoneSymposiaX-8HIVVaccines,Banff,Canada,April9–15,2005.
3. MatobaN,MagérusA,GeyerBC,AlfsenA,HansonCV,ArntzenCJ,BomselMandMorTS.“HumoralimmunityinducedbyCTB-MPR649-684towardsthepreventionofHIV-1mucosaltransmission/infection”in12thInternationalCongressofMucosalImmunology,Boston,MA,June24–30,2005.
4. MatobaN,GeyerBC,AlfsenA,ArntzenCJ,BomselMandMorTS.“Humoralimmunitydirectedatgp41-MPRforthepreventionofHIV-1mucosaltransmission”in5thInternationalConference:AIDSVaccine2006,Amsterdam,Netherlands,August29–September1,2006.
5. MatobaN,MittmanM,GriffinTA,CherniI,AlfsenA,BomselM,ArntzenCJandMorTS“AmucosalsubunitHIV-1vaccinecandidateexpressedinN.benthamiana”inNewCellsforNewVaccines,CoralCables,FL,September28–29,2006.
6. MatobaN,MittmanM,GriffinTA,CherniI,ArntzenCJandMorTS.“ExpressionofanHIV-1vaccinecandidateexpressedinN.benthamianaplant”inPlant-BasedVaccine&Antibodies,Verona,Italy,June18–20,2007.
7. MatobaN,GriffinTA,CherniI,MittmanM,DoranJD,AlfsenA,HansonCV,BomselM,andMorTS.“Transcytosis-blockingAbstargetnon-neutralizingepitopesinthemembraneproximal
NobuyukiMatobaCV
14
regionoftheHIV-1envelopeproteingp41”inKeystoneSymposiaX-7HIVVaccines:ProgressandProspects,Banff,Canada,March26–April1,2008.
8. KessansSA,FraterJ,MatobaN,andMorTS.“PlantexpressionofchimericGag/gp41virus-likeparticlesasamucosally-targetedsubunitvaccineagainstHIV-1”AIDSVaccine2009,Paris,France,October2009
9. MatobaN,CherniI,KessansS,FraterJ,PrestonK,BomselM,andMorTS.“Biochemicalandimmunologicalcharacterizationoftheplant-derivedcandidateHIV-1mucosalvaccineCTB-MPR”AIDSVaccine2009,Paris,France,October2009
10. MatobaN,HuskA,BarnettB,PickelM,ArntzenC,TakahashiA,TannoK,MontefioriD,HansonCandTanakaH.“InitialFeasibilityAnalysisoftheMannoseCluster-specificLectinActinohivinasaCandidateHIV-1Microbicide”TheSecondInternationalConferenceonModernMucosalVaccines,Adjuvants&Microbicides,April28–30,2010,Dublin,Ireland
11. MatobaN,HuskA,BarnettB,ArntzenC,MontefioriD,CaoH,HansonCandTanakaH.“InVitroAnti-HIV-1EfficacyProfileandPlant-basedRecombinantExpressionofActinohivin,anEnvMannoseCluster-specificLectin”2010InternationalMicrobicideConference,May22–25,2010,Pittsburgh,PA–Ireceivedascholarshipawardonthispresentation.
12. HamorskyK,KouokamJC,BennettL,MatobaN.Plant-derivedCholeraToxinBSubunitforAideinMassVaccinationagainstCholera.NewCells,NewVaccineVI,Wilmington,DE,March2012.
13. BaldaufK,KouokamJC,JalaVR,BodduluriH,MatobaN.“APlant-ProducedCholeraToxinBSubunitPreventsAcuteColitisinaMouseModel”2013InternationalCongressofMucosalImmunology,Vancouver,Canada,July2013.
14. HamorskyKT,HuskA,MorrisMK,HansonC,HumeS,DubuissonJ,MatobaN.“Engineering,characterizationandanti-HIV/HCVactivityofAvaren-Fc,anoligomannose-specificlectin-humanIgG1Fcchimera”NextGenerationProteinTherapeuticsSummit,SanFrancisco,CA,June4–6,2014.
15. HamorskyKT,HuskA,KouokamJ,MorrisMK,HansonC,HumeS,Grooms-WilliamsT,VausselinT,DubuissonJ,MatobaN.“AvFc,anoligomannose-specificlectin-humanIgG1Fcchimera,isacandidateantiviralbiotherapeuticagentexhibitingbroadanti-HIV/HCVactivity”ICAAC2014,Washington,DC,September5–9,2014
16. Grooms-WilliamsT,KouokamJC,JensonAB,MatobaN.“ToxicologicalAnalysisofAvaren-Fc:ApotentialHIVmicrobicide”HIVR4P,CapeTown,SouthAfrica,28–31,October2014.
17. HamorskyK,HuskA,MatobaN.“EngineeringandCharacterizationofaBispecificEntryInhibitorfortheNon-VaccineBiomedicalPreventionofHIV-1Infection”HIVR4P,CapeTown,SouthAfrica,28–31,October2014.
18. MatobaN,KouokamC,CaryR,FreelsA,HamorskyK.“ThepotentialofAvFc,anFc-fusedhigh-mannoseglycan-specificlectin,forbroadspectrumanti-cancerimmunotherapy”2015KeystoneSymposiaConferenceJ8:AntibodiesasDrugs:ImmunologicalScaffoldsasTherapeutics,Banff,Canada,February8-13,2015.
NobuyukiMatobaCV
15
19. Hamorsky KT, Seber L, Husk A, Matoba N*. “Engineering, characterization, and anti-HIV activity of a Bispecific HIV Entry Inhibitor” Keystone Symposium: Antibodies as Drugs, Banff, Canada, February 9 – 12, 2015.
20. MatobaN,HuskA,KouokamC,HamorskyK,Grooms-WilliamsT,MahajanG.“AvFc,anovelFcfusionproteintargetingEnvhigh-mannoseglycans”CROI2015,Seattle,WA,February23-26,2015.
21. Zahin M*, Joh J, Khanal S, Husk A, Mason H, Kim S, Matoba N, Jenson A. “Plant-based recombinant vaccine: purification of HPV16 L1 protein and VLPs from tobacco leaves” Plant-Based Vaccines, Antibodies & Biologics. June 8 – 10, 2015, Lausanne, Switzerland.
22. Matoba N*, Husk A, Kouokam JC, Hamorsky K, Grooms T. “A lectibody targeting Env glycans exhibits broad antiviral activity against HIV virions and infected cells” HIV R4P, Chicago, IL, October 17 – 20, 2016.
23. Hamorsky K*, Moore L, Wang L, Rohan L, Palmer K, Matoba N. “Quality studies to support the biopharmaceutical development of the rectal microbicide candidate Griffithsin” HIV R4P, Chicago, IL, October 17 – 20, 2016.
24. Fuqua J*, Hamorsky K, Wang L, Kramzer L, Matoba N, Rohan L, Palmer K. “Characterization of an oxidation resistant griffithsin for use as an HIV microbicide” HIV R4P, Chicago, IL, October 17 – 20, 2016.
25. RoyalJ*,BaldaufK,YaddanapudiK,DrydenGW,MatobaN.“OralAdministrationofaCholeraVaccineAntigenFacilitatesColonicMucosalHealinginaMurineModelofColitis”DigestiveDiseaseWeek2017,Chicago,IL,May6–9,2017.
26. GuoH*,MatobaN,HamorskyK,RoyalJ.“DevelopmentofPETimagingagentsfortargetinghigh-mannose-typeglycansoncancercells”SocietyofNuclearMedicineandMolecularImagingAnnualMeeting,Denver,CO,June10–14,2017.
27. RoyalJ*,OhYJ,GalandiukS,MatobaN.“Epicertinenhancesintestinalwoundhealinginamousecolitismodelandhumanulcerativecolitiscolonexplants”Crohn’s&ColitisCongress,LasVegas,NV,Jan18–20,2018.
PosterPresentations:Local/RegionalMeetings
1. MatobaN,UsuiH,FujitaHandYoshikawaM.“Mechanismofananti-hypertensiveactivityofovokinin,apeptidederivedfromovalbumin”AnnualmeetingofJapanSocietyforBioscience,Biotechnology,andAgrochemistry,Nagoya,Japan,April1998.
2. MatobaN,UsuiHandYoshikawaM.“Designofpotentanti-hypertensivepeptidesbasedonobokininIII”AnnualmeetingofJapanSocietyforBioscience,Biotechnology,andAgrochemistry,Fukuoka,Japan,April1999.
3. MatobaN,DoyamaN,MaruyamaN,UtsumiSandYoshikawaM.“GeneticintroductionofanovokininIIIderivativepeptidepossessingpotentanti-hypertensiveactivityintoaheterologousfoodproteins”AnnualmeetingofJapanSocietyforBioscience,Biotechnology,andAgrochemistry,Tokyo,Japan,April2000.
4. MatobaN,YamadaY,DoyamaN,MaruyamaN,UtsumiSandYoshikawaM.“Designofahighlypotentanti-hypertensivepeptidederivedfromovokininIIIandgeneticintroductionofthe
NobuyukiMatobaCV
16
peptideintoasoybeanprotein”AnnualmeetingofJapanSocietyforBioscience,Biotechnology,andAgrochemistry,Kyoto,Japan,March2001.
5. MatobaN,BarnettB,HuskA,andConwayH.“DevelopmentofPlant-basedHIV-1MicrobicidesandVaccinesTargetingtheEnvelopeHigh-mannoseClusters”Research!Louisville,UniversityofLouisville,Louisville,KY,October2009.
6. MatobaN,BarnettB,HuskA,MontefioriD,andTanakaH.“DevelopmentofPlant-basedHIVMicrobicidesandVaccinesbytargetingtheHigh-mannoseClusterontheEnvGlycoproteingp120”JamesGrahamBrownCancerCenter8thAnnualRetreat,UniversityofLouisville,Louisville,KY,November,2009.–IreceivedRogerH.HerzigJuniorFacultyResearchPrize(3rdplace)
7. HuskA,SankaranS,PalmerKEandMatobaN.“HIV-1NeutralizationProfileandPlant-BasedRecombinantExpressionofActinohivinandDerivatives:ComparingPotencyandgp120BindingAffinityforMonomerandDimerMolecules” Research!Louisville,UniversityofLouisville,October2010– Mr.Husk,ResearchTechinmylab,receivedGrandPrizeinProfessionalStaffcategory.
8. HuskA,SankaranS,PalmerKE,MatobaN.“HIV-1NeutralizationProfileandPlant-BasedRecombinantExpressionofActinohivinandDerivatives:ComparingPotencyandgp120BindingAffinityforMonomerandDimerMolecules”JamesGrahamBrownCancerCenter9thAnnualRetreat,UniversityofLouisville,November,2010.
9. HamorskyK,SankaranS,WalkerJ,PalmerK,MatobaN.“EvaluationofPlant-derivedN-mannosylatedCholeraToxinBsubunitsonMucosalImmunogenicity”JamesGrahamBrownCancerCenter9thAnnualRetreat,UniversityofLouisville,November,2010.
10. HumphreyA,HamorskyK,MettsB,SankaranS,BomselM,MatobaN.“Creationofananti-HIVMicrobicideUsingIgA177”2010KentuckyAcademyofScienceAnnualMeeting,heldatWesternKentuckyUniversity,BowlingGreen,KY,November,2010–Ms.Humphrey,anundergraduate
interninmylab,receivedFirstPlaceintheHealthSciencescategory.
11. LasnikA,MatobaN,PalmerK.Investigationoftheimmunogenicityofgriffithsin-basedvaginalmicrobicidesforHIVprevention.Research!LouisvilleOctober2011.
12. HuskA,SankaranS,HamorskyK,PalmerK,MatobaN.“ProteinEngineeringoftheMannose-SpecificLectinActinohivinforEnhancedAntiviralActivityandRecombinantProducibility”JamesGrahamBrownCancerCenterRetreat,October28,Louisville,KY.
13. HamorskyK,KouokamJ,BennettL,DavisK,PalmerK,MatobaN.“InvestigationofImmunomodulatoryActivityofPlant-derivedCholeraToxinB”JamesGrahamBrownCancerCenterRetreat,October28,Louisville,KY
14. BennettL,HamorskyK,MatobaN.“UtilizationofPlant-derivedCholeraToxinBSubunitforMassVaccinationagainstCholera”2011KentuckyAcademyofScienceAnnualMeeting,heldatMurrayUniversity,Murray,KY,November4–5,2011
15. BaldaufK,KouokamJ,HamorskyK,JalaV,BodduluriH,MatobaN.Oraladministrationofplant-madecholeratoxinBsubunitmitigatesinflammationinamousemodelofcolitis.Research!Louisville,Louisville,KY,September2012.
NobuyukiMatobaCV
17
16. HamorskyK,Grooms-WilliamsT,HuskA,BennettL,PalmerK,MatobaN.“EfficientbioproductionofIgGmonoclonalantibodiesinNicotianaplants.”Research!Louisville,Louisville,KY,September2012.
17. SpeerD,HuskA,MatobaN.“Plant-basedProductionofBi-specificHIVInhibitorasTopicalMicrobicide”2012KentuckyAcademyofScienceUndergraduatePosterPresentation,October19–20,2012,Richmond,KY.–Mr.Speer,anundergraduateinterninmylab,receivedThirdPlaceintheMolecular
andCellularBiologycategory.
18. BaldaufK,KouokamJ,HamorskyK,JalaV,BodduluriH,MatobaN.“Oraladministrationofplant-madecholeratoxinBsubunitmitigatesinflammationinamousemodelofcolitis.”JamesGrahamBrownCancerCenterRetreat,October2012,Louisville,KY.
19. HamorskyK,Grooms-WilliamsT,HuskA,BennettL,PalmerK,MatobaN.“EfficientbioproductionofIgGmonoclonalantibodiesinNicotianaplants.”JamesGrahamBrownCancerCenterRetreat,October2012,Louisville,KY.
20. Grooms-WilliamsT,HamorskyKT,BennettL,HuskA,MatobaN.“SynergisticactivityprofileofthebroadlyHIVneutralizingmonoclonalantibodyVRC01incombinationwithotherHIVinhibitors”JamesGrahamBrownCancerCenterRetreat,October2012,Louisville,KY.
21. HuskA,SpeerD,MatobaN.“Plant-basedProductionofBi-specificHIVInhibitorasTopicalMicrobicide””JamesGrahamBrownCancerCenterRetreat,October2012,Louisville,KY.–Mr.
Husk,SrResearchTechinmylab,receivedSecondPlaceaward.
22. BennettL,HamorskyKT,KouokamJC,BaldaufK,MatobaN.“Aplant-producedcholeratoxinBsubunitvariantdevoidofcrypticN-glycanmodificationretainskeymolecularpropertiesandoralimmunogenicity”JamesGrahamBrownCancerCenterRetreat,October2012,Louisville,KY.
23. BaldaufK,KouokamJC,BodduluriH,MatobaN.“APlant-ProducedCholeraToxinBSubunitPreventsAcuteColitisinaMouseModel”Research!Louisville,Louisville,KY,September2013.
24. HamorskyKT,HuskA,MorrisMK,HansonC,HumeS,DubuissonJ,MatobaN.“Engineering,characterizationandanti-HIV/HCVactivityofAvaren-Fc,anoligomannose-specificlectin-humanIgG1Fcchimera”BrownCancerCenterRetreat,Louisville,KY,October2013
25. HuskA,HamorskyKT,MatobaN.“Plant-basedproductionandcharacterizationofanovelbispecificHIVmicrobicide”BrownCancerCenterRetreat,Louisville,KY,October2013
26. ZahinM,GhimS,JohJ,HumeS,MillerMC,MasonH,MatobaN,JensonAB.“Plantbasedrecombinantvaccine:PurificationofHPV-16L1proteinfromtobaccoleaves”BrownCancerCenterRetreat,Louisville,KY,October2013.
27. KouokamJC,HuskA,BaldaufK,HamorskyKT,MatobaN.“AnOligomannose-specificLectin-FcChimerawithAnti-HIV/HCVActivityExhibitsExcellentinvitroSafetyProfiles”BrownCancerCenterRetreat,Louisville,KY,October2013.
28. Grooms-WilliamsT,HamorskyK,KouokamJ,MorrisMK,HuskA,BaldaufK,HansonC,MatobaN.“ToxicologicalAnalysisofAvaren-Fc:ApotentialHIVvaginalmicrobicide”BrownCancerCenterRetreat,Louisville,KY,October2013.
NobuyukiMatobaCV
18
29. BaldaufK,KouokamJC,BodduluriH,MatobaN.“APlant-ProducedCholeraToxinBSubunitPreventsAcuteColitisinaMouseModel”BrownCancerCenterRetreat,Louisville,KY,October2013.
30. FuquaJ,AugensteinA,RiedellS,LasnikAB,WalkerJ,HamorskyK,MatobaN,PalmerKE.“Next-generationHPVProphylacticVaccines:OptimizingConstructDesignandEvaluatingMucosalImmunizationRoutes”BrownCancerCenterRetreat,Louisville,KY,October2013.
31. RoyalJM,NelsonBA,BaldaufKJ,KouokamJC,MatobaN.Plant-MadeCholeraToxinBSubunit,anOrallyActiveAnti-inflammatoryProtein,inanAcuteColitisMouseModel:InvestigationofEffectiveDoseandTimeofAdministration”Research!Louisville,Louisville,KY,September2014.
32. BaldaufKJ,KouokamJC,JalaVR,BodduluriH,MatobaN.“OralAdministrationofCholeraToxinBSubunitModulatesGastrointestinalProfileandProtectsAgainstDSS-InducedAcuteColitisinMice”Research!Louisville,Louisville,KY,September2014.
33. Grooms-WilliamsT,KouokamJC,JensonAB,MatobaN.“ToxicologicalAnalysisofAvaren-Fc:ApotentialHIVmicrobicide”Research!Louisville,Louisville,KY,September2014.
34. RoyalJM,HuskAS,HamorskyKT,BennettLJ,MatobaN.“Plant-MadeAnti-TNFαMonoclonalAntibody;anInfliximabBiosimilaragainstIntestinalInflammationandColonCancer.”BrownCancerCenterRetreat,Louisville,KY,October2014.
35. BaldaufKJ,KouokamJC,JalaVR,BodduluriH,MatobaN.“OralAdministrationofCholeraToxinBSubunitModulatesGastrointestinalProfileandProtectsAgainstDSS-InducedAcuteColitisinMice”BrownCancerCenterRetreat,Louisville,KY,October2014.
36. KouokamJC,RoyalL,CaryR,FreelA,HuskA,HamorskyK,MatobaN.“EvaluationoftheHIV-1antiviralAvaren-Fcasapotentialcancerimmunotherapeuticdrug.”BrownCancerCenterRetreat,Louisville,KY,October2014.
37. SeberL,HuskA,HamorskyK,MatobaN.“Plant-basedproductionandcharacterizationofanovelbispecificHIVmicrobicide”BrownCancerCenterRetreat,Louisville,KY,October2014.
38. Grooms-WilliamsT,KouokamJC,JensonAB,MatobaN.“ToxicologicalAnalysisofAvaren-Fc:ApotentialHIVmicrobicide”BrownCancerCenterRetreat,Louisville,KY,October2014.
39. RoyalCL,HuskA,HamorskyK,MatobaN.“InvestigationofthecancerimmunotherapeuticpotentialofAvaren-Fc”KentuckyAcademyofScience100thAnnualMeeting,Lexington,KY,November14–16,2014.Mr.Royal,summerinternstudent,won1stplaceintheHealthSciencecategory.
40. Baldauf K*, Royal J, Kouokam J, Dryden G, Matoba N. “Cholera Toxin B Subunit Protects against Colitis-Associated Colon Cancer in a Mouse Model” Ohio Valley Society of Toxicology 2015 Student/Postdoc Summer Meeting. June 29, 2015, Cincinnati, OH.
41. Freels A*, Cary R, Husk A, Matoba N. “The potential of AvFc, a novel plant-produced lectin-Fc fusion molecule, for use in anticancer immunotherapy” Research!Louisville. October 28, 2015, Louisville, KY.
42. Lasnik A*, Matoba N, Palmer K. “Detection of the antiviral lectin in animal and human plasma” Research!Louisville. October 28, 2015, Louisville, KY.
43. Baldauf K, Royal J*, Kouokam J, Dryden G, Matoba N. “Cholera toxin B subunit protects
NobuyukiMatobaCV
19
against colitis-associated colon cancer in a mouse model” Research!Louisville. October 28, 2015, Louisville, KY.
44. Zahin M*, Joh J, Khanal S, Husk A, Mason H, Kim S, Matoba N, Jenson A. “Plant-based recombinant vaccine: purification of HPV16 L1 protein and VLPs from tobacco leaves” Research!Louisville. October 28, 2015, Louisville, KY.
45. Loganathan N*, Ryoal JM, Matoba N. “Plant-Made Cholera Toxin B Subunit: A Molecular Look at Wound Healing Mechanisms.” Research!Louisville. October 2016, Louisville, KY. Ms. Loganathan
received a JGBCC High School Scholars Award (1st place)
46. Hamorsky KT*, Kouokam C, Grooms T, Husk A, Freels A, Guo H, Matoba N. A Lectibody Targeting HIV and Cancer-associated High-mannose Glycans” Research!Louisville. October 2016, Louisville, KY.
47. Royal J*, Baldauf K, Matoba N. “Plant-Made Cholera Toxin B Subunit: a Candidate Oral Immunotherapeutic Agent Enhances Colonic Mucosal Wound Healing.” Research!Louisville. October 2016, Louisville, KY. Mr. Royal received a Master’s Basic Science Graduate Student Award (2nd place)
48. Royal J, Oh Y, Galandiuk S, Matoba N. “Epicertin, A Cholera Toxin B Subunit Variant, Enhances Intestinal Wound Healing in a mouse acute colitis model and human ulcerative colitis colon explants” Research!Louisville, University of Louisville, Sep 12, 2017. Mr. Royal received Master’s
Basic Science Graduate Student Award 1st place
49. Dent M, Guo H, Freels A, Telang S, Matoba N. “A Plant-Produced “Lectibody” Selectively Targets High-Mannose Glycans Overexpressed on the Surface of Cancer Cells: Implications for Novel Cancer Therapeutics/Diagnostics Development” Research!Louisville, University of Louisville, Sep 12, 2017.
PUBLICATIONS
Peer-ReviewedPublications(*corresponding/seniorauthor)
1. MatobaN,UsuiH,FujitaH,YoshikawaM.(1999)Anovelanti-hypertensivepeptidederivedfromovalbumininducesnitricoxide-mediatedvasorelaxationinanisolatedSHRmesentericartery.FEBSLett.452:181-184.(PMID:10386586)
2. YoshikawaM,FujitaH,MatobaN,TakenakaY,YamamotoT,YamauchiR,TsurukiT,TakahataK.(2000)Bioactivepeptidesderivedfromfoodproteinspreventinglifestyle-relateddiseases.BioFactors12:143-146.(PMID:11216476)
3. MatobaN,YamadaY,UsuiH,NakagiriR,YoshikawaM.(2001)Designingpotentderivativesofovokinin(2-7),ananti-hypertensivepeptidederivedfromovalbumin.BiosciBiotechnolBiochem.65:736-739.(PMID:11330703)
4. MatobaN,DoyamaN,YamadaY,MaruyamaN,UtsumiS,YoshikawaM.(2001)Designandproductionofgeneticallymodifiedsoybeanproteinwithanti-hypertensiveactivitybyincorporatingpotentanalogueofovokinin(2-7).FEBSLett.497:50-54.(PMID:11376661)
5. YamadaY,MatobaN,UsuiH,OnishiK,YoshikawaM.(2002).Designofpotentanti-hypertensivepeptidebasedonovokinin(2-7).BiosciBiotechnolBiochem.66:1213-1217.(PMID:12162540)
NobuyukiMatobaCV
20
6. MatobaN,YamadaY,YoshikawaM.(2003)Designofageneticallymodifiedsoybeanproteinpreventinghypertensionbasedonananti-hypertensivepeptidederivedfromovalbumin.CurrMedChem-Cardiovasc&HematolAgents1:197-202.(PMID:15320699)
7. OnishiK,MatobaN,YamadaY,DoyamaN,MaruyamaN,UtsumiS,YoshikawaM.(2004)Optimaldesigningofbeta-conglycinintogeneticallyincorporateRPLKPW,apotentanti-hypertensivepeptide.PEPTIDES25:37-43.(PMID:15003354)
8. MatobaN,MagérusA,GeyerBC,ZhangY,MuralidharanM,AlfsenA,ArntzenCJ,BomselM,MorTS.(2004)AmucosallytargetedsubunitvaccinecandidateelicitingHIV-1transcytosis-blockingAbs.ProcNatlAcadSciUSA.101:13584-13589.(PMID:15347807)
9. MatobaN.(2005)Plant-derivedvaccines:anemergingtechnologytowardsthedistributionofvaccinesindevelopingcountries.Seibutsu-kogakuKaishi83(1):36.InJapanese.
10. MatobaN,ArntzenCJ.(2005)AcurrentperspectiveonmolecularfarmingintheUSA.Invitedreviewfrom:Seibutsu-kogakuKaishi83(11):519-521.InJapanese.
11. MatobaN,GeyerBC,KilbourneJ,AlfsenA,BomselM,MorTS.(2006)Humoralimmuneresponsesbyprime-boostheterologousrouteimmunizationswithCTB-MPR649-684,amucosalsubunitHIV/AIDSvaccinecandidate.Vaccine24:5047-5055.(PMID:16621185)
12. MatobaN,GriffinTA,MittmanM,DoranJD,AlfsenA,MontefioriDC,HansonCV,BomselM,MorTS.(2008)Transcytosis-blockingAbselicitedbyanoligomericimmunogenbasedonthemembraneproximalregionofHIV-1gp41targetnon-neutralizingepitopes.CurrHIVRes3:218-229.(PMID:18473785)
13. MatobaN,KajiuraH,CherniI,DoranJD,BomselM,FujiyamaK,MorTS.(2009)Biochemicalandimmunologicalcharacterizationoftheplant-derivedcandidatehumanimmunodeficiencyvirustype1mucosalvaccineCTB-MPR649-684.PlantBiotechnolJ.7(2):129-145.(PMID:19037902)
14. MatobaN*,HuskAS,BarnettBW,PickelMM,ArntzenCJ,TakahashiA,TannoK,OmuraS,MontefioriDC,MooneyJP,CaoH,HansonCV,TanakaH.(2010)HIV-1NeutralizationProfileandPlant-basedRecombinantExpressionofActinohivin,anEnvGlycan-specificLectinDevoidofT-cellMitogenicActivity.PLoSONE5(6):e11143.(PMID:20559567)
15. MatobaN*,DavisKR,PalmerKE.(2011)RecombinantProteinExpressioninNicotiana.MethodsMolBiol.701:199-219.(PMID:21181532)
16. MatobaN*,ShahN,MorTS*.(2011)HumoralImmunogenicityofanHIV-1EnvelopeResidue649-684Membrane-proximalRegionPeptideFusedtothePlagueAntigenF1-V.Vaccine29(34):5584-5590.(PMID:21693158)
17. KouokamJC,HuskensD,ScholsD,JohannemannA,RiedellSK,WalterW,WalkerJM,MatobaN,O’KeefeBR,PalmerKE.(2011)InvestigationofGriffithsin’sInteractionswithHumanCellsConfirmsItsOutstandingSafetyandEfficacyProfileasaMicrobicideCandidate.PLoSONE6(8):e22635.(PMID:21829638)
18. MatsudaR,TaharaA,MatobaN,FujiwaraK.(2012)VirusVector-MediatedRapidProteinProductioninNicotianabenthamiana:EffectsofTemperatureandPhotosyntheticPhotonFluxDensityonHemagglutininAccumulation.EnvironmentControlinBiology.50(4):375-381.
NobuyukiMatobaCV
21
19. HamorskyKT,KouokamJC,BennettLJ,BaldaufKJ,KajiuraH,FujiyamaK,MatobaN*.(2013)RapidandScalablePlant-basedProductionofaCholeraToxinBSubunitVarianttoAidinMassVaccinationagainstCholeraOutbreaks.PLoSNeglTropDis7(3):2046.(PMID:23505583)
20. HamorskyKT,Grooms-WilliamsT,HuskAS,BennettLJ,PalmerKE,MatobaN*.(2013)Efficientsingletobamoviralvector-basedbioproductionofbroadlyneutralizinganti-HIV-1monoclonalantibodyVRC01inNicotianaplantsanditsutilityincombinationmicrobicides.AntimicrobAgentsChemother.57(5):2076-86.(PMID:23403432)
21. KessansSA,LinhartMD,MatobaN*,MorTS*.(2013)BiologicalandbiochemicalcharacterizationofHIV-1Gag/dgp41virus-likeparticlesexpressedinNicotianabenthamiana.PlantBiotechnolJ.11(6)681-90.(PMID:23506331)
22. FujiuchiN,MatsudaR,MatobaN,FujiwaraK.(2014)EffectofnitrateconcentrationinnutrientsolutiononhemagglutinincontentofNicotianabenthamianaleavesinaviralvector-mediatedtransientgeneexpressionsystem.PlantBiotechnol31(3): 207-211.
23. LeeH,CherniI,YuH,FrommeR,DoranJD,GrotjohannI,BasuS,DornerK,AquilaA,BartyA,BoutetS,ChapmanHN,DoakRB,HogueBG,HunterMS,JamesDR,KirianRA,KupitzC,LawrenceRM,LiuH,NassK,SchlichtingI,SchmidtKE,SeibertMM,ShoemanRL,SpenceJ,StellatoF,WeierstallU,WilliamsGJ,YoonC,WangD,ZatsepinNA,MatobaN,FrommeP,MorTS.(2014)Expression,purificationandcrystallizationofCTB-MPR,acandidatemucosalvaccinecomponentagainstHIV-1.IUCrJ1:305-317.(PMID:25295172)
24. HuskA,HamorskyK,MatobaN*.(2014)MonoclonalAntibodyPurification(NicotianabenthamianaPlants).BioProtoc.20;4(2).pii:e1034.(PMID:27547788)
25. HamorskyKT,KouokamJC,McMullenJ,NelsonB,BennettL,HuskA,KajiuraH,FujiyamaK,MatobaN*.(2015)N-GlycosylationofcholeratoxinBsubunitinNicotianabenthamiana:impactsonhoststressresponse,productionyieldandvaccinepotential.SciRep5:8003.(PMID:25614217)
26. BaldaufKJ,RoyalJM,HamorskyKT,MatobaN*.(2015)CholeratoxinB:Onesubunitwithmanypharmaceuticalapplications.Toxins7:974-996.(PMID:25802972)
27. FuquaJL,HamorskyK,KhalsaG,MatobaN,PalmerKE.(2015)Bulkproductionoftheantivirallectingriffithsin.PlantBiotechnolJ13(8):1160-8.(PMID:26176205)
28. MatobaN*.(2015)N-GlycosylationofcholeratoxinBsubunit:serendipityfornovelplant-madevaccines?FrontPlantSci6:1132.(PMID:26732492)
29. FujiuchiN,MatsudaR,MatobaN,FujiwaraK.(2016)RemovalofBacterialSuspensionWaterOccupyingtheIntercellularSpaceofDetachedLeavesafterAgroinfiltrationImprovestheYieldofRecombinantHemagglutinininaNicotianabenthamianaTransientGeneExpressionSystem.BiotechnolBioeng113(4):901-6.(PMID:26461274)
30. FujiuchiN,MatobaN,MatsudaR(2016)EnvironmentControltoimproverecombinantproteinyieldsinplantsbasedonAgrobacterium-mediatedtransientgeneexpression.FrontBioengBiotechnol4:23.doi:10.3389/fbioe.2016.00023.(PMID:27014686)
31. KessansSA,LinhartM,MeadorLR,KilbourneJ,FrommeP,MatobaN,MorTS.(2016)
NobuyukiMatobaCV
22
Immunologicalcharacterizationofplant-basedHIV-1gag/dgp41virus-likeparticles.PLoSONE11(3):e0151842.(PMID:26986483)
32. ZahinM,JohJoongho,KhanalS,HuskA,MasonH,WarzechaH,GhimShin-je,MillerD,MatobaN,JensonA(2016)Plant-basedrecombinantvaccine:PurificationofHPV16L1proteinandVLPsfromtobaccoleaves.PLoSONE11(8):e0160995.(PMID:27518899)
33. GroomsTN,VuongHR,TyoKM,MalikDA,SimsLB,WhittingtonCP,PalmerKE,MatobaN*,Steinback-RankinsJM*.(2016)Griffithsin-ModifiedElectrospunFibersasaDeliveryScaffoldtoPreventHIVInfection.AntimicrobAgentsChemother60:6518-6531.*co-senior/correspondingauthors(PMID:27550363)
34. BaldaufKJ,RoyalJM,KouokamJC,HaribabuB,JalaVR,YaddanapudiK,HamorskyKT,DrydenGW,MatobaN*.(2017)OraladministrationofarecombinantcholeratoxinBsubunitpromotesmucosalhealinginthecolon.MucosalImmunol10:887-900.(PMID:27805617)
35. FujiuchiN,MatsudaR,MatobaN,FujiwaraK.(2017)EffectsofplantdensityonrecombinanthemagglutininyieldsinanAgrobacterium-mediatedtransientgeneexpressionsystemusingNicotianabenthamianaplants.BiotechnolBioeng114(8):1762-1770.(PMID:28369753)
36. MatsudaR,AbeT,FujiuchiN,MatobaN,FujiwaraK.(2017)EffectoftemperaturepostviralvectorinoculationontheamountofhemagglutinintransientlyexpressedinNicotianabenthamianaleaves.JBioschiBioeng124(3):346-350.(PMID:28460871)
37. HughesMG,TuckerWW,ReddyS,BrierME,KochD,McClainCJ,JonssonCB,MatobaN,ChungD.(2017)RateofHepatitisCViralUptakebyHumanLiversinHumanPatients:LiverTransplantationModelingPrimaryInfectionandImplicationsforStudyingEntryInhibition.PLoSONE12(7):e0180719.(PMID:28732019)
38. RoyalJM,MatobaN*.(2017)TherapeuticpotentialofCholeraToxinBSubunitforthetreatmentofinflammatorydiseasesofthemucosa.Toxins.9(12).pii:E379.(PMID:29168738)
39. RoychowdhuryS,OhYJ,KajiuraH,HamorskyKT,FujiyamaK,MatobaN*.(2018)HydroponictreatmentofNicotianabenthamianawithkifunensinemodifiestheN-glycansofrecombinantglycoproteinantigenstopredominantlyMan9high-mannosetypeupontransientoverexpression.FrontPlantSci9:62.doi:10.3389/fpls.2018.00062.(PMID: 29441088)
40. GirardL,BirseK,HolmJB,GajerP,HumphrysMS,GarberD,GuenthnerP,Noël-RomasL,AbouM,McCorristerS,WestmacottG,WangL,RohanLC,MatobaN,McNichollJ,PalmerKE,RavelJ,BurgenerA.(2018)Impactofthegriffithsinanti-HIVmicrobicideandplacebogelsontherectalmucosalproteomeandmicrobiomeinnon-humanprimates.SciRep8:8059.
Non-peerreviewedarticles,Bookchapters,Proceedings,PamphletorBulletin
1. YoshikawaM,MatobaN,NakagiriR,FujitaHandSasakiR.(1997)OvokininisanagonistforangiotensinAT2receptors.InPeptideChemistry1996TheJapanesePeptideSociety,pp.141-144.
2. OnishiK,MatobaN,YamadaY,UtsumiS,MaruyamaNandYoshikawaM.(2003)Designofhighlyfunctionalsoybeanproteinbygeneticintroductionofanti-hypertensivepeptide.InPeptideScience2002(Ed.byT.Yamada),TheJapanesePeptideSociety,pp.123-126.
3. MatobaNandMorTS.(2006)Plant-derivedsubunitvaccines.In:PlantGeneticEngineeringvol.8:MetabolicEngineering&Molecularpharming–II”Jaiwal,P.K.andSingh,R.P.(Eds.),HaworthPressInc.,NewYork,pp143-183.
4. ShahN,MatobaN,ChangH,HuJ,MorTS.(2008)Plagueantigenfusionswithgp41membraneproximalregionasHIVvaccinecandidate.InVitroCellDevBiolAnim.44:Supplement,S72-73.
NobuyukiMatobaCV
23
5. MatobaN,KajiuraH,CherniI,DoranJD,BomselM,FujiyamaK,MorTS.(2008)InplantaexpressionandmolecularcharacterizationofthecandidateHIV-1mucosalvaccineCTB-MPR649-684.InVitroCellDevBiolAnim.44:Supplement,S35.
6. KessansS,MatobaN,MorTS.(2008)PlantexpressionofchimericGag/gp41virus-likeparticlesasasubunitvaccineagainstHIV-1.InVitroCellDevBiolAnim.44:Supplement,S72.
7. CherniI,VassallA,MatobaN,MorTS.(2008) MPR649-684-HepBcoreantigenfusionforrnsvirus-likeparticlesinplantsandisimmunogenicinmice.InVitroCellDevBiolAnim.44:Supplement,S57.
8. CherniI,VassallA,KessansS,MatobaN,MorTS.(2008)ChimericPlant-ExpressedHIV-1gp41MembraneProximalRegionDisplayedonHepatitisBCapsidVirus-LikeParticlesisImmunogenicinMice.AIDSResHumRetroviruses24,p39.
9. KessansSA,FraterJ,MatobaN,andMorTS.(2009)PlantexpressionofchimericGag/gp41virus-likeparticlesasamucosally-targetedsubunitvaccineagainstHIV-1.Retrovirology6:Supplement3,p15.
10. MatobaN,CherniI,KessansS,FraterJ,PrestonK,BomselM,MorTS.(2009)Biochemicalandimmunologicalcharacterizationoftheplant-derivedcandidateHIV-1mucosalvaccineCTB-MPR.Retrovirology6:Supplement3,p182.
11. MatobaN*.(2012)VaccineDevelopmentandProductioninPlants.In:TheBasicsofFoodImmunology,YoshikawaandKaminogawa,Eds.Invitedbookchapter.ArticleinJapanese.
12. MatobaN,MatsudaR.(2014)RapidproductionofmonoclonalantibodytherapeuticsandvaccinesinNicotianabenthamiana“plantfactories”.Bioscience&Industry72(2)102-108.Invitedreviewarticle(inJapanese).
13. Grooms-Williams T, Joseph K, Alfred J, Matoba N. (2014) Toxicological Analysis of Avaren-Fc: A Potential HIV Microbicide. AIDS Res Hum Retroviruses. 30(S1): A155-A156.
14. Hamorsky K, Husk A, Matoba N. (2014) Engineering and Characterization of a Bispecific Entry Inhibitor for Non-vaccine Biomedical Prevention of HIV-1 Infection. AIDS Res Hum Retroviruses. 30(S1): A263-A263.
15. MasonHS,ThuenemannE,KiyonoH,KessansS,MatobaN,MorTS.(2015)Chapter65–MucosalVaccinesfromPlantBiotechnology.In:MucosalImmunology(FourthEdition).MesteckyJ,StroberW,RussellMW,CheroutreH,LambrechtBN,KelsallBL.(Eds).Vol2,pp.1271–1289.
16. MooreL,HamorskyKT*,MatobaN*.(2016)ProductionofrecombinantcholeratoxinBsubunitinNicotianabenthamianausingGENEWARE®tobaccomosaicvirusvector.MethodsMolBiol1385:129-37.(PMID:26614286)
17. HamorskyKT*,MatobaN*.(2016)FacilemethodfortheproductionofrecombinantcholeratoxinBsubunitinE.coli.MethodsMolBiol1404:511-8.(PMID:27076319)
18. RoyalJM,BaldaufKJ,YaddanapudiK,DrydenGW,MatobaN*.(2017)Oraladministrationofacholeravaccineantigenfacilitatescolonicmucosalhealinginamurinemodelofcolitis.Gastroenterology152(5):S572-S573.
Recommended